Clinical Trials on Hypertension, Ocular

Total 14612 results

Aerie Pharmaceuticals

Completed

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

Ocular Hypertension | Glaucoma

United States
Guy's and St Thomas' NHS Foundation Trust

Unknown

Aqueous Dynamics and Glaucoma Surgeries

Ocular Hypertension | Glaucoma

United Kingdom
Allergan

Completed

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Japan
Allergan

Completed

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Canada
Alcon Research

Completed

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®

Ocular Hypertension | Glaucoma
University of Zurich

Unknown

Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines

Ocular Hypertension | Glaucoma

Switzerland
Alcon Research

Completed

Patient Preference Study

Ocular Hypertension | Glaucoma
Allergan

Completed

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

Ocular Hypertension | Glaucoma

United States
Taiwan Otsuka Pharm. Co., Ltd

Completed

A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension Patients

Glaucoma

Taiwan
Sensimed AG
Clinique de Montchoisi, Lausanne, Switzerland

Completed

Use of an Ocular Telemetry Sensor in Diamox Treated Patients

Ocular Hypertension | Glaucoma

Switzerland
Larissa University Hospital

Completed

Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination

Ocular Hypertension | Glaucoma

Greece
Alcon Research

Completed

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients

Ocular Hypertension | Glaucoma

United States
Fidia Farmaceutici s.p.a.

Recruiting

Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy

Dry Eye Syndrome | Glaucoma and Concomitant Dry Eye Syndrome | Ocular Hypertension and Concomitant Dry Eye Syndrome | Multiple Long-term Topical Hypotensive Therapy

Italy
Allergan

Completed

A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin

Ocular Hypertension

United States
Future Medicine
Futuremedicine Australia

Recruiting

FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension

Ocular Hypertension

Australia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Efficacy and Tolerability of Xalatan in Patients (A6111128)

Ocular Hypertension | Glaucoma

Egypt, Saudi Arabia, United Arab Emirates
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of Glaucoma or Ocular Hypertension in Patients Within the United States

Ocular Hypertension | Glaucoma

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US (XLT)

Ocular Hypertension | Glaucoma

United States
Washington University School of Medicine
National Eye Institute (NEI)

Completed

Ocular Hypertension Treatment Study (OHTS) (OHTS)

Ocular Hypertension | Glaucoma
Allergan

Completed

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Aerie Pharmaceuticals

Completed

Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Philadelphia Eye Associates
Pfizer

Completed

Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops

Ocular Hypertension | Glaucoma

United States
Merck Sharp & Dohme LLC

Completed

MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

Glaucoma
Alcon Research

Completed

Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Japan
University of Zurich

Unknown

Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients

Ocular Hypertension | Glaucoma

Switzerland
Allergan

Completed

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
The New York Eye & Ear Infirmary
National Eye Institute (NEI)

Completed

Ocular Hypertension Treatment Study (OHTS)

Ocular Hypertension | Glaucoma
Allergan

Completed

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Allergan

Withdrawn

Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Allergan

Completed

Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

China
Meir Medical Center

Unknown

Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom

Glaucoma | Hypertension

Israel
Allergan

Completed

Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
Chakshu Research, Inc.

Completed

An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

Ocular Hypertension

United States
Novartis

Completed

Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension

Ocular Hypertension

Australia
Allergan

Completed

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Innovative Medical

Completed

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Glaucoma

United States
Mayo Clinic

Terminated

Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear

Ocular Hypertension

United States
University of Houston

Completed

The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width

Ocular Hypertension

United States
Sensimed AG
Yale University

Terminated

IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients

Ocular Hypertension

United States
Intuor Technologies, Inc.

Completed

Clinical Evaluation of CATS Tonometer Prism

Ocular Hypertension

United States
United States Naval Medical Center, San Diego

Completed

Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning

Ocular Hypertension

United States
University of Nebraska

Completed

Circadian Rhythms of Aqueous Humor Dynamics When Using Brimonidine in Humans With Ocular Hypertension

Glaucoma Suspects

United States

3

Subscribe